FDA Investigator Luz I Collado

Luz I Collado has conducted inspections on 66 sites in 4 countries as of 05 Apr 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Luz I Collado's Documents

Publish Date Document Type Title
July, 2000 EIR Isaac Bassan, M.D. - EIR, 2000-07-25
November, 2001 FDA 483 Response Kalman, Leonard A., M.D. - Form 483R, 2001-12-18
September, 2000 FDA 483 ICSL Clinical Studies Ltd. - Form 483, 2000-09-28
January, 2001 FDA 483 Response Peninsular Testing Corp. - Form 483R, 2001-02-21
December, 2004 FDA 483 Jayaweera, Dushyantha, M.D. - Form 483, 2004-12-17
June, 2002 EIR SFBC International Inc. - EIR, 2002-06-14
February, 2001 EIR SFBC International Inc. - EIR, 2001-02-09
January, 2001 FDA 483 Peninsular Testing Corp. - Form 483, 2001-01-18
March, 2001 EIR Beckman Coulter, Inc. - EIR, 2001-04-12
January, 2002 FDA 483 Beckman Coulter, Inc. - Form 483, 2002-01-11
March, 2001 FDA 483 Response Beckman Coulter, Inc. - Form 483R, 2001-04-10
December, 2002 FDA 483 Response Non-Invasive Monitoring Systems, Inc. - Form 483R, 2002-12-17
November, 2001 EIR Kalman, Leonard A., M.D. - EIR, 2001-11-30
September, 2000 FDA 483 Response Maria J. Gutierrez, MD - Form 483R, 2000-10-18
April, 2000 FDA 483 Response Dr. Constantino Mangioni, MD - Form 483R, 2000-07-25
December, 2002 EIR Non-Invasive Monitoring Systems, Inc. - EIR, 2002-12-04
September, 2000 EIR Maria J. Gutierrez, MD - EIR, 2000-11-09
June, 2002 FDA 483 SFBC International Inc. - Form 483, 2002-06-14
December, 2002 FDA 483 Non-Invasive Monitoring Systems, Inc. - Form 483, 2002-12-04
November, 2000 EIR Paul Joel Goodnick, M.D. - EIR, 2000-11-28
July, 2000 FDA 483 Pharma Research - Form 483, 2000-07-18
May, 2001 EIR Kasi Sridhar, M.D. - EIR, 2001-05-21
May, 2001 FDA 483 Kasi Sridhar, M.D. - Form 483, 2001-05-01
January, 2002 EIR Beckman Coulter, Inc. - EIR, 2002-01-11
May, 2003 EIR Margaret Fischl, M.D. - EIR, 2003-05-02
February, 2003 FDA 483 Teva Branded Pharmaceutical Products R & D, Inc. - Form 483, 2003-02-28
June, 2003 EIR David J. Seiden, M.D. - EIR, 2003-06-13
November, 2001 FDA 483 Kalman, Leonard A., M.D. - Form 483, 2001-11-30
April, 2000 FDA 483 St. Gerardo di Monza Hospital - Form 483, 2000-04-20
February, 2003 EIR Teva Branded Pharmaceutical Products R & D, Inc. - EIR, 2003-02-28
April, 2000 FDA 483 Response Simonsen, Ernst, M.D. - Form 483R, 2000-05-18
June, 2002 EIR SFBC International Inc. - EIR, 2002-06-14
March, 2001 FDA 483 Beckman Coulter, Inc. - Form 483, 2001-03-27
July, 2001 FDA 483 Beckman Coulter INC. - Form 483, 2001-07-27
April, 2000 EIR Dr. Constantino Mangioni, MD - EIR, 2000-06-12
February, 2001 FDA 483 Response SFBC International Inc. - Form 483R, 2001-03-05
February, 2001 FDA 483 SFBC International Inc. - Form 483, 2001-02-09
July, 2001 EIR Beckman Coulter, Inc. - EIR, 2001-07-27
April, 2000 EIR Simonsen, Ernst, M.D. - EIR, 2000-06-12
June, 2003 FDA 483 David J. Seiden, M.D. - Form 483, 2003-06-17
November, 2000 FDA 483 Univ. of Miami, School of Medicine, Dept. of Psychiatry - Form 483, 2000-11-28
January, 2001 EIR Peninsular Testing Corp. - EIR, 2001-01-26
April, 2000 FDA 483 LINKOPINGS UNIV - Form 483, 2000-04-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more